IDO1 and melanoma: Of interest, Treg-mediated immune tolerance may occur through the control of IFN-I on indoleamine 2,3-dioxygenase (IDO) (38, 39), being melanoma peritumoral IDO expression by pDCs an early marker of resistance (40).